Rules of Their Own: Is Britain's Post-Brexit Regulatory Independence a Blessing or a Burden?
Eight years on from the referendum, the promise of a nimbler, self-governing regulatory state is being tested against commercial reality. Across sectors from pharmaceuticals to financial services, British businesses are discovering that sovereignty over rule-making carries a price — and that price is not always distributed evenly.